‘Auto Artists For Ukraine’ Selling Works With 100% Proceeds To The Red Cross Ukraine Crisis Appeal
We Want To Announce An Automotive Artist-Led Initiative To Create A Charitable Response To The…
News
Travere Announces Proposed Convertible Senior Notes Offering
SAN DIEGO, March 08, 2022 (GLOBE NEWSWIRE) — Travere Therapeutics, Inc. (Nasdaq: TVTX) today announced…
Imara to Webcast Conference Call of Full Year 2021 Financial Results and Business Highlights
BOSTON, March 08, 2022 (GLOBE NEWSWIRE) — Imara Inc. (Nasdaq: IMRA), a clinical-stage biopharmaceutical company…
Avalo to Present at Oppenheimer’s 32nd Annual Healthcare Conference
WAYNE, Pa. and ROCKVILLE, Md., March 08, 2022 (GLOBE NEWSWIRE) — Avalo Therapeutics, Inc. (Nasdaq:…
Altimmune to Report Fourth Quarter and Full Year 2021 Financial Results on March 15, 2022
GAITHERSBURG, Md., March 08, 2022 (GLOBE NEWSWIRE) — Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharmaceutical…
PROCEPT BioRobotics Reports Fourth Quarter and Full Year 2021 Financial Results
REDWOOD CITY, Calif., March 08, 2022 (GLOBE NEWSWIRE) — PROCEPT® BioRobotics (Nasdaq: PRCT) (the “Company”),…
Calithera to Present Data Highlighting Newly Discovered Synthetic Lethal Target VPS4 at AACR 2022 Annual Meeting
First data from preclinical synthetic lethality program of novel VPS4A inhibitors with potential for clinical…
Optinose Reports Fourth Quarter and Full Year 2021 Financial Results and Recent Operational Highlights
Company reports fourth quarter and full year 2021 XHANCE net revenue of $22.5 million and…
Good Supply Brand Expands Its Award-Winning Cannabis Portfolio with Hash Bats™; A New ‘Hard-Hitting’ Infused Pre-Roll
Good Supply Hash Bats Educational overview of a Hash Bat. TORONTO, March 08, 2022 (GLOBE…
Harvard Bioscience Announces Fourth Quarter 2021 Financial Results
Revenue up 7% year-over-year as sales momentum continues, despite global supply chain headwinds Gross margin…
Sigilon Therapeutics to Present at the Barclays Global Healthcare Conference
CAMBRIDGE, Mass., March 08, 2022 (GLOBE NEWSWIRE) — Sigilon Therapeutics, Inc. (NASDAQ: SGTX), a biotechnology…
First Wave BioPharma to Participate in ”Fireside Chat” at the 34th Annual Roth Conference
Fireside Chat scheduled for Tuesday, March 15, 2022, at 9:30 a.m., PT BOCA RATON, Fla.,…
PolyPid to Deliver Poster Presentation at SAGES 2022
Presentation Evaluates Efficacy of D-PLEX100 in Reducing Surgical Site Infection Rates in Elective Colorectal Surgery…
Quotient Limited Announces Receipt of CE Mark for the Extended Immunohematology Microarray
The Extended Immunohematology microarray provides labs with comprehensive characterization, simplified workflow, and high throughput—all on…
MiroBio Continues Expansion of Executive Leadership Team with Key Appointments to Advance Development of Checkpoint Agonist Antibodies for Autoimmune Disease
Sanjay Keswani, MBBS, FRCP Sanjay Keswani, MBBS, FRCP Lynne Murray, Ph.D., MBA Lynne Murray, Ph.D.,…
Entera Bio Reports Financial Results for the Year Ended December 31, 2021
— EB613 expected to commence pivotal Phase 3 Osteoporosis trial in 2022 —— New EB612…
Matinas BioPharma Reports Fourth Quarter and Full Year 2021 Financial Results and Operational Highlights
– Fifteen Patients Enrolled to Date in Cohort 4 of EnACT (all oral induction regimen);…
Voyager Therapeutics Reports Fourth Quarter and Full Year 2021 Financial and Operating Results
License option agreement with Novartis for target-specific access to TRACER™ next-generation AAV capsids for potential use…
Xüdle’s New Profitability Guide Helps Wineries Increase Sales in Current Economic Climate
New e-book provides wineries of all sizes with tips to improve bottom line revenue and…
RETRANSMISSION: HIVE Blockchain Provides Update on February 2022 Production and At-The-Market Offering and Conclusion of Canadian At-The-Market Offering
This news release constitutes a “designated news release” for the purposes of the Company’s prospectus…